down arrow

Cathay Biotech, Inc.

  • Market Cap: Large Cap
  • Industry: Specialty Chemicals
  • ISIN: CNE100004447
CNY
45.43
-0.51 (-1.11%)

Dec 04

SHG

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

36.8156.16
Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Poor Management Efficiency with a low ROCE of 8.99%

  • The company has been able to generate a Return on Capital Employed (avg) of 8.99% signifying low profitability per unit of total capital (equity and debt)
2

Poor long term growth as Net Sales has grown by an annual rate of 16.68% and Operating profit at -6.18% over the last 5 years

 
3

The company has declared Positive results for the last 4 consecutive quarters

4

With ROE of 3.01%, it has a attractive valuation with a 1.70 Price to Book Value

5

Underperformed the market in the last 1 year

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Specialty Chemicals

stock-summary
Market cap

CNY 29,630 Million (Large Cap)

stock-summary
P/E

56.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.79%

stock-summary
Debt Equity

-0.53

stock-summary
Return on Equity

3.01%

stock-summary
Price to Book

1.70

Revenue and Profits:
Net Sales:
895 Million
(Quarterly Results - Jun 2025)
Net Profit:
173 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-12.3%
0%
-12.3%
6 Months
-3.09%
0%
-3.09%
1 Year
0.93%
0%
0.93%
2 Years
-16.04%
0%
-16.04%
3 Years
-28.89%
0%
-28.89%
4 Years
-59.83%
0%
-59.83%
5 Years
-32.47%
0%
-32.47%

Cathay Biotech, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Cathay Biotech Hits Day High with Strong 4.71% Intraday Surge

Cathay Biotech Hits Day High with Strong 4.71% Intraday Surge

Cathay Biotech, Inc. has shown strong performance in the specialty chemicals sector, with a notable increase on October 27, 2025. The company reported a 35.4% rise in profits over the past year and maintains a solid cash position, reflecting its robust market standing despite recent fluctuations.

Read More
Cathay Biotech Stock Hits Day Low of CNY 50.08 Amid Price Pressure

Cathay Biotech Stock Hits Day Low of CNY 50.08 Amid Price Pressure

Cathay Biotech, Inc. faced a decline in stock value on October 14, 2025, amid a challenging trading environment. Despite recent fluctuations, the company has reported positive quarterly results and maintains a strong cash position. Its valuation metrics indicate operational stability, although long-term performance has been mixed.

Read More
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
16.68%
EBIT Growth (5y)
-6.18%
EBIT to Interest (avg)
99.33
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.52
Sales to Capital Employed (avg)
0.18
Tax Ratio
15.23%
Dividend Payout Ratio
47.53%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
8.99%
ROE (avg)
4.40%
Valuation key factors
Factor
Value
P/E Ratio
56
Industry P/E
Price to Book Value
1.70
EV to EBIT
52.27
EV to EBITDA
28.59
EV to Capital Employed
2.49
EV to Sales
6.39
PEG Ratio
1.59
Dividend Yield
0.79%
ROCE (Latest)
4.76%
ROE (Latest)
3.01%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 16.76% vs 4.36% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 38.78% vs -8.74% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "895.00",
          "val2": "766.50",
          "chgp": "16.76%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "198.80",
          "val2": "209.10",
          "chgp": "-4.93%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.70",
          "val2": "7.00",
          "chgp": "-90.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "2.20",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "172.50",
          "val2": "124.30",
          "chgp": "38.78%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "122.40%",
          "val2": "168.70%",
          "chgp": "-4.63%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 40.05% vs -13.65% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 16.18% vs -33.33% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,922.10",
          "val2": "2,086.50",
          "chgp": "40.05%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "675.90",
          "val2": "440.30",
          "chgp": "53.51%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "33.50",
          "val2": "37.90",
          "chgp": "-11.61%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "474.60",
          "val2": "408.50",
          "chgp": "16.18%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "119.90%",
          "val2": "72.20%",
          "chgp": "4.77%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary
Jun'25
Mar'25
Change(%)
Net Sales
895.00
766.50
16.76%
Operating Profit (PBDIT) excl Other Income
198.80
209.10
-4.93%
Interest
0.70
7.00
-90.00%
Exceptional Items
2.20
0.00
Consolidate Net Profit
172.50
124.30
38.78%
Operating Profit Margin (Excl OI)
122.40%
168.70%
-4.63%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2025 is 16.76% vs 4.36% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is 38.78% vs -8.74% in Mar 2025

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
2,922.10
2,086.50
40.05%
Operating Profit (PBDIT) excl Other Income
675.90
440.30
53.51%
Interest
33.50
37.90
-11.61%
Exceptional Items
0.00
0.00
Consolidate Net Profit
474.60
408.50
16.18%
Operating Profit Margin (Excl OI)
119.90%
72.20%
4.77%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 40.05% vs -13.65% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 16.18% vs -33.33% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Cathay Biotech, Inc. stock-summary
stock-summary
Cathay Biotech, Inc.
Specialty Chemicals
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."